Marshall Wace, LLP IMMUNOMEDICS INC Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
N/A
-161,222 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
N/A
32,770 Added 25.51%
161,222 $13.7 Million
Q2 2020

Aug 13, 2020
BUY
N/A
128,452 New
128,452 $4.55 Million
Q1 2020

May 15, 2020
SELL
N/A
-297,513 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
N/A
-206,695 Reduced 40.99%
297,513 $6.3 Million
Q3 2019

Nov 14, 2019
SELL
N/A
-97,908 Reduced 16.26%
504,208 $6.69 Million
Q2 2019

Aug 14, 2019
BUY
N/A
602,116 New
602,116 $8.35 Million
Q1 2019

May 14, 2019
SELL
N/A
-279,917 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
N/A
279,917 New
279,917 $3.99 Million
Q2 2018

Aug 14, 2018
SELL
N/A
-11,800 Closed
0 $0
Q1 2018

May 15, 2018
BUY
N/A
11,800 New
11,800 $172,000
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email